Open AccessExpression of a soluble TGF-β receptor by tumor cells enhances dendritic cell/tumor fusion vaccine efficacy.
Author(s) -
M. Zhang,
B. E. Berndt,
J.-J. Chen,
J. Y. Kao
Publication year - 2008
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.181.10.7428-b
Subject(s) - receptor , dendritic cell , cancer research , microbiology and biotechnology , transforming growth factor , tumor cells , immunology , chemistry , biology , immune system , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom